Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles 2025-08-06
  2. Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer's disease in a multicenter and multiethnic aging population 2025-06-23
  3. Clinical value of novel blood-based tau biomarkers in Creutzfeldt-Jakob disease 2024-12-06

Studies

5 studies carry this tag.

Date range

2020 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Cells 1
  • European journal of nuclear medicine and molecular imaging 1
  • Nature aging 1
  • NeuroImage. Clinical 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. European journal of nuclear medicine and molecular imaging 2025-08-06 Biomarkers

    Plasma pTau217 is effective for predicting A/T biomarker profile and cognitive decline, though further study is needed to better explain its association with Aβ and tau PET staging.

  2. Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer's disease in a multicenter and multiethnic aging population

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Nature aging 2025-06-23 Biomarkers

    Over 20% of patients with Alzheimer's disease (AD) worldwide are Chinese, although the efficacy of existing blood-based measures of AD biomarkers is largely unknown in Asian cohorts.

  3. Clinical value of novel blood-based tau biomarkers in Creutzfeldt-Jakob disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-12-06 Biomarkers

    Plasma BD-tau is a valuable marker for CJD prognostication.

  4. Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Cells 2023-04-18 Biomarkers

    This paper highlights the growing evidence that blood-based tau biomarkers have early diagnostic utility for Alzheimer's disease.

  5. The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. NeuroImage. Clinical 2020-07-02 Treatments

    This study shows preliminary data on the potential combined effect of amyloid-β and tau-related pathologies on the integrity of posterior brain cortices in DLB patients, whereas only amyloid-β seems to be related to MTA.

All topic tags with their study counts